Ladenburg Thalmann Financial Services’s NanoViricides NNVC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$0 Buy
+1
New +$2 ﹤0.01% 5438
2019
Q3
Hold
0
5387
2019
Q2
Hold
0
5359
2019
Q1
Hold
0
5288
2018
Q4
Sell
-75
Closed -$480 5285
2018
Q3
$1K Hold
75
﹤0.01% 5012
2018
Q2
$1K Hold
75
﹤0.01% 5001
2018
Q1
$1K Hold
75
﹤0.01% 5001
2017
Q4
$1K Hold
75
﹤0.01% 4908
2017
Q3
$2K Buy
75
+25
+50% +$671 ﹤0.01% 4683
2017
Q2
$1K Hold
50
﹤0.01% 4748
2017
Q1
$1K Hold
50
﹤0.01% 4725
2016
Q4
$1K Sell
50
-93
-65% -$2.48K ﹤0.01% 4682
2016
Q3
$5K Hold
143
﹤0.01% 4164
2016
Q2
$5K Hold
143
﹤0.01% 4135
2016
Q1
$6K Hold
143
﹤0.01% 3983
2015
Q4
$3K Hold
143
﹤0.01% 4241
2015
Q3
$3K Hold
143
﹤0.01% 4150
2015
Q2
$5K Hold
143
﹤0.01% 4057
2015
Q1
$6K Hold
143
﹤0.01% 3899
2014
Q4
$8K Hold
143
﹤0.01% 3527
2014
Q3
$9K Buy
143
+93
+186% +$7.3K ﹤0.01% 3163
2014
Q2
$4K Buy
+50
New +$3.55K ﹤0.01% 3458
2014
Q1
Hold
0
3818
2013
Q4
Hold
0
3806

Other funds holding NNVC

Ladenburg Thalmann Financial Services's NNVC Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services opened a new position in NanoViricides (NNVC) in Q4 2019: 1 share worth $0. The stake represents ﹤0.01% of the portfolio and ranks #5438 among its holdings. This is a return to the name: Ladenburg Thalmann Financial Services previously reported a position in NNVC as recently as Q3 2018.

Ladenburg Thalmann Financial Services first reported a position in NNVC in Q2 2014 and has held it in 19 quarters since. The position peaked at $9K in Q3 2014. 21 funds tracked by Wall St. Rank hold NNVC as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 1 share of NanoViricides worth $0 as of Q4 2019.
  • NanoViricides was a new Ladenburg Thalmann Financial Services position in Q4 2019.
  • NanoViricides made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5438 holding.
  • Ladenburg Thalmann Financial Services first reported a position in NanoViricides in Q2 2014 and has held it in 19 quarters since.
  • Ladenburg Thalmann Financial Services's NanoViricides position peaked at $9K in Q3 2014.
  • 21 funds tracked by Wall St. Rank held NanoViricides as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.